BHC-13 |
A |
09:00 AM - 09:10 AM |
MECHANISTIC DETAILING OF COAGULATION FACTOR XIII STRUCTURE |
SNEHA SINGH |
BHC-20 |
A |
09:10 AM - 09:20 AM |
SIGNIFICANCE OF MIXING STUDY IN LUPUS ANTICOAGULANT AND VARIOUS FORMULAE USED TO INTERPRET RESULTS |
MAITREYI PATWARDHAN |
BHC-25 |
A |
09:20 AM - 09:30 AM |
APPLICATION AND ADHERENCE OF DEEP VEIN THROMBOSIS (DVT) PROPHYLAXIS RISK ASSESSMENT MODEL IN ICU PATIENTS IN A TERTIARY CARE HOSPITAL |
JUILEE CHARMODE |
BHC-27 |
A |
09:30 AM - 09:40 AM |
ONE STAGE FVIII ASSAY FOR LABORATORY MONITORING OF EXTENDED HALF-LIFE FACTORS IN HEMOPHILIA A: CHALLENGES AND SOLUTIONS. |
BIPIN KULKARNI |
BHC-30 |
A |
09:40 AM - 09:50 AM |
PREVALENCE OF ALLOIMMUNISATION IN BETA THALASSEMIA MAJOR AT TERTIARY CARE CENTER |
PRIYA BORKAR |
BHC-40 |
A |
09:50 AM - 10:00 AM |
EFFICACY AND SAFETY OF MIM8 PROPHYLAXIS IN ADULTS AND ADOLESCENTS WITH HEMOPHILIA A WITH OR WITHOUT INHIBITORS: PHASE 3, OPEN LABEL, RANDOMIZED, CONTROLLED FRONTIER2 STUDY |
NITA RADHAKRISHNAN |
BHL-10 |
B |
09:00 AM - 09:10 AM |
UNACCEPTABLE RESULTS FOR MICROSCOPIC PERIPHERAL SMEAR EXAMINATION : A PARTICIPATING LABORATORY ANALYSIS. |
RAJESHWARI HANDIGUND |
BHL-13 |
B |
09:10 AM - 09:20 AM |
BORDERLINE HBA2 LEVELS: ARE WE MISSING SOMETHING? |
SHALINI SINGH |
BHL-14 |
B |
09:20 AM - 09:30 AM |
LIKELIHOOD OF IDENTIFYING A HLA-MATCHED RELATED OR UNRELATED DONOR FOR INDIAN PATIENTS SEEKING STEM CELL TRANSPLANTATION |
SUREKA RAJENDRAN |
BHL-18 |
B |
09:30 AM - 09:40 AM |
STRATEGIES FOR SMALL LABORATORIES THAT ARE ECONOMICAL IN TERMS OF INTERNAL QUALITY CONTROL |
KALPESH GOLVANKAR |
BHL-19 |
B |
09:40 AM - 09:50 AM |
PREVALENCE OF KIR-B HAPLOTYPE AND KIR ALLOREACTIVITY IN DONORS OF HAPLOIDENTICAL HEMATOPOIETIC CELL TRANSPLANTATION: A SINGLE CENTER STUDY FROM INDIA |
KANISHKA CHAURASIA |
BHL-21 |
B |
09:50 AM - 10:00 AM |
COMPARING THE DIAGNOSTIC ACCURACY OF DETECTING RED BLOOD CELLS IN URINE USING LIGHT MICROSCOPIC EXAMINATION, PHASE CONTRAST MICROSCOPIC EXAMINATION AND AN AUTOMATED URINE ANALYSER |
PRERNA PRASAD |
MHC-12 |
C |
09:00 AM - 09:10 AM |
TREATMENT OUTCOME IN ADOLESCENT AND YOUNG ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) ON BFM-95 PROTOCOL: EXPERIENCE OF A TERTIARY CARE INSTITUTE FROM NORTH INDIA. |
ALPIKA SHUKLA |
MHC-13 |
C |
09:10 AM - 09:20 AM |
OUTCOMES OF DLBCL TREATED FROM 2011 TO 2020: AN AUDIT FROM AN EASTERN INDIA TERTIARY CANCER CENTER. |
SREYA DAS |
MHC-14 |
C |
09:20 AM - 09:30 AM |
YOUNG PATIENTS WITH DLBCL IN INDIA: INITIAL 1-YEAR OUTCOMES REVEAL AGGRESSIVE DISEASE AND FAVORABLE RESPONSES DESPITE HIGH LOSS TO FOLLOW-UP |
SUVIR SINGH |
MHC-16 |
C |
09:30 AM - 09:40 AM |
OUTCOMES IN ADULT HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH) WITH LOW DOSE CYCLOPHOSPHAMIDE: A SINGLE CENTRE PILOT STUDY |
SUSHMA BAISHYA |
MHC-17 |
C |
09:40 AM - 09:50 AM |
FLAT-DOSE NIVOLUMAB-BASED COMBINATION REGIMENS FOR TREATMENT OF RELAPSE REFRACTORY HODGKIN LYMPHOMA : REAL-WORLD EVIDENCE FROM A LOWER MIDDLE-INCOME COUNTRY |
NIHAR DESAI |
MHC-18 |
C |
09:50 AM - 10:00 AM |
FEASIBILITY OF AZACITIDINE AND VENETOCLAX FOLLOWED BY HIGH/INTERMEDIATE DOSE CYTARABINE (HIDAC/IDAC) CONSOLIDATION IN PREVIOUSLY UNTREATED ACUTE MYELOID LEUKEMIA PATIENTS UNFIT FOR INTENSIVE CHEMOTHERAPY - A |
AMIYA RANJAN NAYAK |
MHL-7 |
D |
09:00 AM - 09:10 AM |
TRBC1 AS A SURROGATE MARKER FOR CLONALITY IN TCR ALPHA/BETA POSITIVE T-CELL NEOPLASM BY MULTICOLOUR FLOWCYTOMETRY. |
SUBHAJIT BRAHMA |
MHL-8 |
D |
09:10 AM - 09:20 AM |
THE BIOPSY PRESENTATION OF ACUTE LYMPHOBLASTIC LEUKEMIA AND ITS CORRELATION WITH CLINICAL OUTCOMES |
SHAURYA VIJAYRAN |
MHL-9 |
D |
09:20 AM - 09:30 AM |
EXPRESSION OF CD304 IN PEDIATRIC B CELL ACUTE LYMPHOBLASTIC LEUKAEMIA AND ITS ROLE IN MEASURABLE RESIDUAL DISEASE (MRD) MONITORING |
NEHA . |
MHL-10 |
D |
09:30 AM - 09:40 AM |
IMMUNOHISTOCHEMICAL EXPRESSION OF MUTANT NPM1 IN ADULT ACUTE MYELOID LEUKEMIA |
S R DEEPA |
MHL-11 |
D |
09:40 AM - 09:50 AM |
THE GENETIC CHARACTERIZATION AND OUTCOME ANALYSIS OF ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE : A GRAY ZONE ENTITY |
AMRITHA SARAVANAN |
MHL-12 |
D |
09:50 AM - 10:00 AM |
CORRELATION OF CYTOGENETIC ABERRATIONS WITH CLINICAL CHARACTERISTICS AND TREATMENT OUTCOME IN MULTIPLE MYELOMA |
KRUTI CHAUBAL |
MH-2 |
E |
09:00 AM - 09:08 AM |
CLINICO-HEMATOLOGICAL PROFILES OF MYELODYSPLASIA RELATED MUTATIONS IN ACUTE MYELOID LEUKEMIAS. |
PRAKHAR GUPTA |
MH-3 |
E |
09:08 AM - 09:16 AM |
NOT EVERYTHING HAIRY IS A HAIRY CELL - EVADING THE TRAP, A CASE SERIES OF SEVEN CASES |
MOHAMMED N MEERA |
MH-4 |
E |
09:16 AM - 09:24 AM |
QUANTITATION OF LEUKEMIC STEM CELL-LIKE CELLS (LSC) BURDEN AT DIAGNOSIS IDENTIFIES CLINICAL HETEROGENEITY IN EUROPEAN LEUKEMIANET 22 (ELN22) RISK STRATIFICATION OF ACUTE MYELOID LEUKEMIA (AML) |
AARTI ACHREKAR |
MH-5 |
E |
09:24 AM - 09:32 AM |
MOLECULAR CHARACTERISATION OF BETA-THALASSEMIA IN ANTENATAL SCREENING SAMPLES AT A TERTIARY CARE CENTRE IN CENTRAL INDIA |
DIVYANSHI GARKOTI |
MH-6 |
E |
09:32 AM - 09:40 AM |
MOLECULAR WORK UP OF UNEXPLAINED ERYTHROCYTOSIS IN YOUNG PATIENTS OF INDIAN ORIGIN, A STUDY CONDUCTED AT TERTIARY CENTRE IN NORTH INDIA. |
PRATYUSHA GUDAPATI |
MH-7 |
E |
09:40 AM - 09:48 AM |
IMPACTS OF WT1 GENE GENOMIC AND EPIGENOMIC ABERRATIONS ON PROGNOSIS IN ACUTE MYELOID LEUKEMIA WITHIN THE INDIAN POPULATION |
EKTA RAHUL |
BHL-32 |
E |
09:48 AM - 09:56 AM |
THE SPURIOUSLY HIGH NEUTROPHIL CELL COUNTER POPULATION DATA IN APML- A CASE SERIES |
SNEHIL KUMAR |
BHL-30 |
E |
09:56 AM - 10:04 AM |
PROGNOSTIC CORRELATIONAL STUDY OF HEMOGLOBIN INDICES WITH RISING MELD SCORES |
VIRENDRA BHAD |
BHL-28 |
E |
10:04 AM - 10:12 AM |
SPECTRUM OF HAEMOGLOBINOPATHIES IN ANTENATAL WOMEN IN A TERTIARY CARE CENTRE. |
DAMINI SAINI |
BHL-22 |
E |
10:12 AM - 10:20 AM |
TITLE: COMPARISON OF IMMATURE PLATELET FRACTION (IPF) BETWEEN NORMOTENSIVE AND PRE-ECLAMPTIC PREGNANT FEMALES |
SONALIKA PRIYADARSHINI SAHOO |
BHL-20 |
E |
10:20 AM - 10:28 AM |
EXPERIENCE OF NEW BORN SCREENING FOR HEMOGLOBINOPATHIES AT TERTIARY CARE CENTER IN VIDARBHA OVER 18 MONTHS: IDENTIFYING CHALLENGES AND SOLUTIONS |
APURVA RAMTEKE |
BHL-17 |
E |
10:28 AM - 10:36 AM |
BONE MARROW GRANULOMAS - INSIGHTS AND IMPLICATIONS. |
GURPREET KAUR |
BHL-12 |
E |
10:36 AM - 10:44 AM |
IMMUNOPHENOTYPIC PROFILE IN A PEDIATRIC PATIENT MIMICKING MALIGNANT LYMPHOPROLIFERATIVE DISORDER |
SAVITRI SINGH |
BHL-33 |
E |
10:44 AM - 10:52 AM |
PRP CLOUD: NO SURGERY SOLUTION FOR KNEE OSTEOARTHRITIS: A REVOLUTIONARY GAME CHANGER |
AKASH SAOLI |
BHC-1 |
E |
06:30 PM - 06:38 PM |
PERFORMANCE CHARACTERISTICS OF % HYPOCHROMIC RED CELLS IN THE DETECTION OF LATENT IRON DEFICIENCY IN WOMEN WITH MENOMETRRORHAGIA |
VIVEK GEORGE |
BHC-2 |
E |
06:38 PM - 06:46 PM |
INTEGRATING CLINICAL FEATURES AND GENETIC FACTORS WITH BLOOD COMPONENT USE IN ACUTE LEUKEMIA |
SANKALP SHARMA |
BHC-4 |
E |
06:46 PM - 06:54 PM |
LOW HEMOGLOBIN IS NOT ALWAYS IRON DEFICIENCY ANEMIA. AT LEAST IN NILGIRIS, TAMIL NADU |
ANCY ABRAHAM |
BHC-6 |
E |
06:54 PM - 07:02 PM |
EFFICACY OF ROMIPLOSTIM IN NEWLY DIAGNOSED APLASTIC ANAEMIA. |
MADHUPRIYA B |
BHC-7 |
E |
07:02 PM - 07:10 PM |
RETICULOCYTE HEMOGLOBIN: A NOVEL PARAMETER FOR DETECTING IRON REPLETE STATUS AMONG REGULAR FEMALE BLOOD DONORS |
DIVYA T |
BHC-8 |
E |
07:10 PM - 07:18 PM |
CLINICAL PROFILE OF INHERITED PLATELET DISORDERS IN CHILDREN: A SINGLE CENTRE RETROSPECTIVE STUDY |
ANWESHA SINGH |
BHC-14 |
E |
07:18 PM - 07:26 PM |
BLOOD GROUP DISTRIBUTION PATTERNS IN VOLUNTARY BLOOD DONORS- AN OBSERVATIONAL STUDY |
ADITYA RANE |
MHC-9 |
E |
07:26 PM - 07:34 PM |
REAL-WORLD EXPERIENCE WITH GENERIC VENETOCLAX PLUS HYPOMETHYLATING AGENT INDUCTION THERAPY IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS IN RESOURCE-LIMITED SETTING: A SINGLE-CENTER STUDY FROM AIIMS |
ARJUN ARJUN |
MHC-32 |
E |
07:34 PM 07:42 PM |
RETROSPECTIVE ANALYSIS OF OUTCOMES OF 7-DAY COURSE OF VENTOCLAX WITH HYPOMETHYLATING AGENT IN NEWLY DIAGNOSED PATIENTS OF AML : SINGLE CENTRE EXPERIENCE |
BHAVANI MANDAVA |